Essentiale® Paste in Patients With Gastrointestinal Symptoms in Acute or Chronic Liver Diseases

Summary

Primary Objective: To assess safety of Phosphatidylcholine paste 600 mg (ESSENTIALE® paste) oral 3 times a day for 12 weeks in patients with gastrointestinal symptoms in acute and chronic liver diseases. Secondary Objectives: To assess effectiveness on symptomatic improvement in patients with gastrointestinal symptoms in acute and chronic liver diseases. To monitor compliance.

Timeline

Start

2015-08

Primary completion

2016-06

Completion

2016-06

Drugs

Indications